X

    XOMA Royalty Corporation (XOMAP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $24.98
    +0.00 (+0.00%)

    Last updated: Aug 31, 2026 at 5:00 PM ET

    Earnings

    Upcoming Estimates

    Period ending Mar 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $14M
    Range$12M - $16M
    2 analysts
    Period ending Jun 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $16M
    Range$16M - $16M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-N/A---
    Jun 26EST
    		-N/A---
    Mar 26EST
    		-N/A---
    Sep 25
    Reported Nov 12
    		$0.70$0.00N/ABeat+171.4%
    Jun 25
    Reported Aug 15
    		$0.44$0.00N/ABeat+168.8%
    Mar 25
    Reported May 13
    		$0.06$0.00N/ABeat+112.5%
    Dec 24
    Reported Mar 17
    		$-0.45$0.00N/AMiss+15.1%
    Mar 23
    Reported May 9
    		$-0.98$0.00N/AMiss-206.2%
    Dec 22
    Reported Mar 9
    		$-0.64$0.00N/AMiss-137.9%
    Sep 22
    Reported Nov 3
    		$-0.48$0.00N/AMiss+5.9%
    Jun 22
    Reported Aug 4
    		$-0.53$0.00N/AMiss-71.0%
    Mar 22
    Reported May 5
    		$-0.32$0.00N/AMiss+54.3%
    Dec 21
    Reported Mar 8
    		$1.69$0.00N/ABeat+32.0%
    Sep 21
    Reported Nov 4
    		$-0.51$0.00N/AMiss-410.0%
    Jun 21
    Reported Aug 5
    		$-0.31$0.00N/AMiss+6.1%
    Mar 21
    Reported May 6
    		$-0.70$0.00N/AMiss-42.9%
    Dec 20
    Reported Mar 10
    		$1.28$0.00N/ABeat+361.2%
    Sep 20
    Reported Nov 5
    		$-0.10$0.00N/AMiss+74.0%
    Jun 20
    Reported Aug 6
    		$-0.33$0.00N/AMiss-263.0%
    Mar 20
    Reported May 5
    		$-0.49$0.00N/AMiss-5.0%
    Dec 19
    Reported Mar 10
    		$-0.49$0.00N/AMiss-232.0%
    Sep 19
    Reported Nov 5
    		$-0.38$0.00N/AMiss-7.7%
    Jun 19
    Reported Aug 6
    		$0.20$0.00N/ABeat+136.8%
    Mar 19
    Reported May 6
    		$-0.47$0.00N/AMiss-100.5%
    Dec 18
    Reported Mar 7
    		$0.37$0.00N/ABeat+180.7%
    Sep 18
    Reported Nov 7
    		$-0.36$0.00N/AMiss-227.2%
    Jun 18
    Reported Aug 7
    		$-0.55$0.00N/AMiss-127.7%
    Mar 18
    Reported May 9
    		$-0.23$0.00N/AMiss-127.3%
    Dec 17
    Reported Mar 7
    		$-0.46$0.00N/AMiss+80.6%
    Sep 17
    Reported Nov 6
    		$-0.11$0.00N/AMiss+96.2%
    Jun 17
    Reported Aug 8
    		$1.98$0.00N/ABeat-
    Mar 17
    Reported May 9
    		$0.85$0.00N/ABeat-
    Dec 16
    Reported Mar 16
    		$-2.37$0.00N/AMiss-
    Sep 16
    Reported Nov 9
    		$-2.89$0.00N/AMiss-

    Dividends

    Dividend Metrics

    Yield8.63%
    Annual/Share$2.16
    Payout Ratio566.14%
    Frequency4
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+0.24%
    View XOMAP's full dividend history

    Key Metrics

    Valuation
    P/E Ratio33.31EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin69.60%Operating Margin-3.90%
    ROE34.20%ROIC21.81%
    Financial Health
    Debt/Equity0.91xInterest Coverage3.55x
    Current Ratio3.59xQuick Ratio3.59x
    Trading Statistics
    Beta0.86Avg VolumeN/A
    52-Week High$27.6352-Week Low$23.90

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$24.98
    SMA 20$24.98
    SMA 50$24.97
    SMA 200$25.03
    EMA 10$24.98
    EMA 20$24.98
    EMA 50$24.98
    EMA 200$24.84

    MACD

    Line: 0.00Signal: 0.00Hist: -0.00

    ADX

    ADX: 49.1+DI: 3.6-DI: 11.1

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down100.0
    PSAR$25.19

    Bollinger Bands

    Upper Band$24.98
    Lower Band$24.98
    %B PositionN/A
    Band Width0.50

    RSI (14-Day)

    Neutral
    54.3

    Momentum Oscillators

    Stoch %KN/A
    Stoch %DN/A
    Williams %RN/A
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)N/A
    MFI (14d)N/A

    Volatility Measures

    ATR (14d)$0.03(0.1%)
    StdDev (20d)N/A
    Hist VolN/A

    Volume Flow

    VWAP$24.98
    OBV-4.4K
    AD Line-617943955208.3B
    CMF (20d)N/A

    Volume Metrics

    Avg Vol (20d)N/A
    Vol RatioN/A
    VWMA (20d)N/A

    Pivot Points

    R3$24.98
    R2$24.98
    R1$24.98
    Pivot Point$24.98
    S1$24.98
    S2$24.98
    S3$24.98

    Advanced Oscillators

    TSI9.71
    Ultimate OscN/A
    KST0.20

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$12.32M$1.43M$532,000$13.13M$15.91M$8.71M$7.20M$11.09M$1.49M$1.83M$830,000$1.66M
    Cost of Revenue$895,000$135,000$878,000$655,000$1.29M$201,000$817,000$1.16M$2,000$25,000$25,000$39,000
    Gross Profit$11.42M$1.43M$532,000$12.47M$14.62M$8.51M$6.38M$9.93M$1.49M$1.81M$805,000$1.62M
    Operating Expenses$11.90M$-750,000$1.86M$7.87M$8.69M$24.77M$22.02M$20.00M$8.49M$21.74M$6.59M$7.58M
    R&D$49,000$281,000$69,000$69,000$1.29M$864,000$817,000$1.16M$33,000$25,000$25,000$39,000
    SG&A$11.86M$10.41M$9.73M$7.80M$8.11M$6.99M$7.98M$10.95M$8.46M$7.41M$6.33M$5.72M
    Operating Income$-480,000$2.18M$-1,330,000$4.60M$5.93M$-16,253,000$-15,640,000$-10,079,000$-7,004,000$-19,934,000$-5,787,000$-5,957,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$3.72M$3.03M$3.30M$3.24M$3.47M$3.39M$3.49M$3.40M$3.55M$569,000$0$0
    Income Before Tax$4.47M$6.16M$14.10M$9.19M$2.37M$-9,626,000$-17,243,000$15.98M$-8,595,000$-20,109,000$-5,509,000$-5,400,000
    Income Tax Expense$1,000$54,000$49,000$0$0$-5,658,000$0$0$-41,276$-8,647,000$-278,000$1.02M
    Net Income$4.46M$6.10M$14.05M$9.19M$2.37M$-3,968,000$-17,243,000$15.98M$-8,595,000$-20,109,000$-5,509,000$-5,400,000
    EBITDA$9.08M$10.07M$18.28M$13.09M$6.38M$-6,024,000$-13,747,000$19.39M$-5,042,000$-7,031,000$-5,285,000$-4,157,000
    EBIT$8.19M$9.18M$17.40M$12.43M$5.83M$-6,232,000$-13,750,000$19.39M$-5,044,000$-7,256,000$-5,509,000$-4,382,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XOMAP

    News

    XOMA Royalty Corp (XOMA) Income Statement

    This page provides the quarterly and annual income statements for XOMA Royalty Corp (XOMA), displaying detailed financial data such as total revenue, operating expenses, net income, and earnings per share from FY2012Q1 through FY2026Q1. It also includes frequently asked questions about how to interpret the income statement, key metrics for analyzing the stock, and XOMA Royalty Corp's recent financial performance. Investors can use this information to assess the company's financial health and operational efficiency over time.

    TradingKey•7/25/26•
    Neutral

    XOMAP | XOMA Royalty Corporation 8.625% Insider Trading

    This article provides an overview of XOMA Royalty Corporation (XOMAP), focusing on its real-time price, financials, institutional holdings, and insider trading activity. It notes a lack of recent congressional trading, whale activity, and insider trading reported for XOMAP. The company specializes in acquiring economics associated with pre-commercial therapeutic candidates in biotechnology.

    Quiver Quantitative•6/18/26•
    Neutral

    XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

    XOMA Royalty Corporation has declared quarterly cash dividends for its Series A and Series B Cumulative Perpetual Preferred Stock and announced the redemption of all outstanding shares of this Preferred Stock on July 14, 2026. This redemption is linked to the pending merger between XOMA and Ligand Pharmaceuticals. Additionally, the record date for the distribution of contingent value rights (CVRs) to XOMA common stockholders, as part of the merger consideration, has been set for July 13, 2026.

    Yahoo Finance•6/13/26•
    Somewhat-Bullish

    XOMA Corp - 8.375% DP PFD B declares $0.5234 dividend

    XOMA Corp's 8.375% DP PFD B shares have declared a dividend of $0.5234. This announcement provides key financial information for investors tracking preferred stock dividends.

    MSN•6/13/26•
    Somewhat-Bullish

    Frequently Asked Questions About XOMAP

    What is XOMAP's current dividend yield?
    XOMA Royalty Corporation (XOMAP) has a current dividend yield of 8.63%.
    Does XOMAP pay dividends?
    Yes, XOMA Royalty Corporation pays dividends with a current yield of 8.63%.
    What is XOMAP's P/E ratio?
    XOMA Royalty Corporation has a price-to-earnings (P/E) ratio of 33.31.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In